yanjie Cao

Prof. Dr. yanjie Cao


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KZKun Zheng
Kun Zheng
MWMengdi Wu
Mengdi Wu
YCyanjie Cao
yanjie Cao
JWJunhua Wang
Junhua Wang
HZHuijing Zhu
Huijing Zhu
XPXiuming Pan
Xiuming Pan
Circadian rhythm disruption is increasingly prevalent and associated with higher morbidity and mortality. This study investigates the relationship between Circadian Rhythm Syndrome (CircS) and mortality in middle-aged and older adults. This prospective cohort study utilized mortality follow-up data from the China Health and Retirement Longitudinal Study (CHARLS) and the National Health and Nutrition Examination Survey (NHANES). Cox proportional hazards models examined the association between CircS and all-cause mortality, while restricted cubic spline analysis explored non-linear relationships. Subgroup analyses investigated potential modifying factors. Cox models and Bayesian generalized linear models were used to explore relationships between CircS and specific causes of death. The study included 7,637 participants from CHARLS (2011–2020) and 9,320 participants from NHANES (2005–2018), with 142 and 1,321 all-cause deaths. The follow-up periods were 9.17 years for CHARLS and 15 years for NHANES. CircS was significantly associated with increased all-cause mortality risk (CHARLS: HR 1.79, 95% CI: 1.23–2.62; NHANES: HR 1.21, 95% CI: 1.03–1.42). A linear dose-response relationship was observed between the number of CircS components and mortality risk. CircS was positively associated with mortality from diabetes, cardiovascular, cerebrovascular, and kidney-related diseases. CircS is strongly associated with increased mortality risk. These findings underscore the importance of addressing circadian disruptions in public health strategies.

29 May 2025 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
BLBowen Li
Bowen Li
YXYue Xu
Yue Xu
QHQingwei He
Qingwei He
QYQiaoxiang Yin
Qiaoxiang Yin
MWMengdi Wu
Mengdi Wu
YCyanjie Cao
yanjie Cao
Background: Cardiovascular diseases (CVDs) are among the leading causes of mortality worldwide, with abdominal aortic calcification (AAC) being an independent risk factor. The serum uric acid (sUA) to high-density lipoprotein cholesterol (HDL-C) ratio (UHR) integrates both pro-atherogenic (sUA-induced endothelial dysfunction) and anti-atherogenic factors (HDL-C-mediated cholesterol efflux), which may be associated with vascular calcification. However, epidemiological evidence on their relationship remains scarce.Methods: This cross-sectional study analyzed data from 2,789 U.S. adults aged ≥40 years in the National Health and Nutrition Examination Survey (NHANES) 2013–2014 with complete AAC and UHR data. Participants with invalid AAC imaging, missing sUA/HDL-C measurements, or incomplete calcium/phosphorus intake records were excluded. AAC severity was quantified using the Kauppila scoring system via dual-energy x-ray absorptiometry. UHR was calculated as [sUA [mg/dl] divided by HDL-C [mg/dl]] multiplied by 100. Weighted multivariable linear and logistic regression models assessed associations, while weighted restricted cubic splines explored nonlinear relationships. Subgroup analyses and sensitivity analyses assessed the robustness of findings.Results: The study included a total of 2,789 participants aged 40 or older. After multifactorial adjustment, the regression model indicated that a higher UHR was significantly associated with increased AAC scores (β = 1.055, 95%CI: 1.024–1.087), AAC (OR = 2.605, 95%CI:1.760–3.855), and severe AAC (OR = 2.227, 95%CI:1.649–3.008). The restricted cubic spline analysis revealed significant nonlinear relationships between UHR and both AAC scores and AAC, presenting an inverted “L” shape, with the risk rising sharply at UHR levels close to 17.8–18.0 and then plateauing. Subgroup analyses suggested potential interactions between gender and diabetes in the UHR-AAC association, while sensitivity analyses confirmed the stability of the findings.Conclusion: In a U.S. middle-aged and elderly population, the UHR was found to be nonlinearly associated with the risk of AAC, and may interact with gender and diabetes. However, due to the cross-sectional design, no causal inferences can be drawn. Future longitudinal studies may be considered to validate these associations and explore whether interventions targeting UHR could potentially slow down the progression of vascular calcification.

1 October 2025 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
BLBowen Li
Bowen Li
YXYue Xu
Yue Xu
HZHuijing Zhu
Huijing Zhu
QHQingwei He
Qingwei He
QYQiaoxiang Yin
Qiaoxiang Yin
YCyanjie Cao
yanjie Cao
Background: Type 2 diabetes mellitus (T2DM) is closely associated with chronic inflammation. However, the value of low-cost, readily accessible complete blood count (CBC)-derived inflammatory indicators in predicting all-cause mortality among T2DM patients has not been fully evaluated. This study evaluated their predictive potential. Methods: This single-center retrospective cohort included 619 T2DM patients. Associations between nine inflammatory indicators and all-cause mortality were assessed using multivariable-adjusted Cox regression models. Time-dependent ROC curves, Kaplan-Meier (K-M) analysis, restricted cubic spline (RCS) models, and subgroup analyses evaluated predictive performance and stability. Results: Over a median follow-up of 1058 days, 137 deaths (22.1%) occurred. Patients in the highest quartile (Q4) of the systemic inflammation response index (SIRI, HR=2.486, 95% CI:1.291,4.788), neutrophil-to-lymphocyte ratio (NLR, HR=2.275, 95% CI:1.217,4.252), and neutrophil-monocyte to lymphocyte ratio (nMLR, HR=2.212, 95% CI:1.200,4.077) had significantly elevated mortality risk versus the lowest quartile (Q1) after adjustment (P for trend< 0.01 for all). RCS confirmed significant positive linear associations (P for nonlinearity> 0.05). Predictive ability attenuated over time per time-dependent ROC. Subgroup analyses demonstrated consistent associations across clinical subgroups (P for interaction> 0.05). Conclusion: SIRI, NLR, and nMLR can independently predict all-cause mortality in T2DM patients and demonstrate stable performance across clinical subgroups. These low-cost, routinely tested biomarkers possess the potential to optimize risk stratification in resource-limited settings.

30 July 2023 in Clinical Case Reports
Verified
Journal Article
Open access
XLXiao‐Hua Lan
Xiao‐Hua Lan
YHYue Hu
Yue Hu
YCyanjie Cao
yanjie Cao
PLPing Liu
Ping Liu
QRQi‐Tao Ren
Qi‐Tao Ren
WZWei‐Wei Zhu
Wei‐Wei Zhu
Key Clinical Message: Linezolid (LZD) is an efficient addition antibiotic against multidrug‐resistant strains. However, clinicians should pay attention to the adverse reactions such as hypoglycemia and anemia in using LZD, especially in elderly patients and patients with abnormal liver and kidney function who need to use LZD for a long time. Severe hypoglycemia and anemia caused by linezolid (LZD) are rare, with potentially serious adverse effects. The report of LZD‐induced hypoglycemia and anemia is extremely rare. Thus far, this is the first report. We presented LZD‐induced recurrent hypoglycemia and anemia in a 93‐year‐old patient who has been prescribed LZD 600 mg once daily for 42 days for treatment of tuberculosis (TB) pleurisy and pneumonia. The patient began to experience recurrent hypoglycemic episodes and anemia 5 days and 2 weeks after LZD medication, respectively. Using Naranjo's Adverse Drug Reaction Assessment Scale, the patient scored 8 points with the category of “probable”. His hypoglycemia and anemia gradually improved 1 month after LZD withdrawal. Clinicians should pay attention to the adverse reactions such as hypoglycemia and anemia in using LZD, especially in elderly patients and patients with abnormal liver and kidney function who need to use LZD for a long time. Patients should regularly monitor blood routine, blood glucose, and liver and kidney functions during LZD exposure, which may avoid adverse reactions and improve their prognosis.

23 May 2024 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
XLXiaohua Lan
Xiaohua Lan
HZHuijing Zhu
Huijing Zhu
YCyanjie Cao
yanjie Cao
YHYue Hu
Yue Hu
XFXingman Fan
Xingman Fan
MWMengdi Wu
Mengdi Wu
Background: This systematic review and meta-analysis aimed to explore the effects of different sodium–glucose cotransporter-2 inhibitors (SGLT2i) on prognosis and cardiac structural remodeling in patients with heart failure (HF).Methods: Relevant studies published up to 20 March 2024 were retrieved from PubMed, EMBASE, Web of Science, and Cochrane Library CNKI, China Biomedical Literature Service, VIP, and WanFang databases. We included randomized controlled trials of different SGLT2i and pooled the prognosis data of patients with HF. We compared the efficacy of different SGLT2i in patients with HF and conducted a sub-analysis based on left ventricular ejection fraction (LVEF).Results: We identified 77 randomized controlled trials involving 43,561 patients. The results showed that SGLT2i significantly enhanced outcomes in HF, including a composite of hospitalizations for HF and cardiovascular death, individual hospitalizations for HF, Kansas City Cardiomyopathy Questionnaire (KCCQ) scores, left atrial volume index (LAVi), and LVEF among all HF patients (P < 0.05) compared to a placebo. Sotagliflozin was superior to empagliflozin [RR = 0.88, CI (0.79–0.97)] and dapagliflozin [RR = 0.86, CI (0.77–0.96)] in reducing hospitalizations for HF and CV death. Dapagliflozin significantly reduced hospitalizations [RR = 0.51, CI (0.33–0.80)], CV death [RR = 0.73, CI (0.54–0.97)], and all-cause mortality [RR = 0.69, CI (0.48–0.99)] in patients with HF with reduced ejection fraction (HFrEF). SGLT2i also plays a significant role in improving cardiac remodeling and quality of life (LVMi, LVEDV, KCQQ) (P < 0.05). Among patients with HF with preserved ejection fraction (HFpEF), SGLT2i significantly improved cardiac function in HFpEF patients (P < 0.05). In addition, canagliflozin [RR = 0.09, CI (0.01–0.86)] demonstrated greater safety compared to sotagliflozin in a composite of urinary and reproductive infections of HFpEF patients.Conclusion: Our systematic review showed that SGLT2i generally enhances the prognosis of patients with HF. Sotagliflozin demonstrated superiority over empagliflozin and dapagliflozin in a composite of hospitalization for HF and CV death in the overall HF patients. Canagliflozin exhibited greater safety compared to sotagliflozin in a composite of urinary and reproductive infections of HFpEF. Overall, the efficacy of SGLT2i was greater in HFrEF patients than in HFpEF patients.

3 July 2023 in Heliyon
Verified
Journal Article
Open access
YHYue Hu
Yue Hu
XLXiao-Hua Lan
Xiao-Hua Lan
YCyanjie Cao
yanjie Cao
JDJing-Qi Duan
Jing-Qi Duan
QRQi-Tao Ren
Qi-Tao Ren
RDRuibing Deng
Ruibing Deng
The number of centenarians with cancer is increasing as the global population ages. The diagnosis and treatment for centenarians with tumor sometimes are specific, and there are currently less appropriate guidelines as references. We report a 104-year-old man with asymptomatic primary liver cancer (PLC) whose family decided to receive conservative and palliative care. The patient has been followed up for 27 months. He has been mainly received Chinese herbal medicine (CHM), nutritional support and thymalfasin injection intermittently, etc. During the 27-month follow-up, the patient has showed good compliance and tolerance without any complications of the tumor. Conclusion: Individualized palliative care and complementary medicine, based on multidisciplinary evaluation, traditional Chinese medicine, consultation with patients and their families about treatment options, etc., may help improve the life quality of centenarians with end-stage tumors.